Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks

In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts.

The S&P 500 surged to an unprecedented milestone, closing at an historic 5,200 level following signals from the Federal Reserve regarding potential interest rate cuts in 2024. This significant move in the market reflects Wall Street traders’ optimism about the prospect of the Fed adjusting its monetary policy in response to economic conditions. The Federal Reserve’s indication of a potential shift in its approach to interest rates prompted a rally in short-term bonds, as investors reacted to the reassurance of forthcoming cuts. The central bank’s communication, including the ‘dot plot’ which confirmed expectations of three rate cuts within the year, provided clarity to market participants and fueled confidence in future economic stability. This development comes amid ongoing global economic shifts, including challenges within China’s property market, as highlighted by Bain Capital’s assessment that there is no immediate solution to the issues faced. Despite these broader economic concerns, the Fed’s decision to maintain rates unchanged while signaling potential cuts has injected optimism into financial markets. The rally in equities was widespread, with various sectors experiencing gains, particularly those that had previously underperformed, such as small-cap stocks. This suggests a broad-based confidence in the resilience of corporate profits, bolstered by the anticipated supportive monetary policy. Moreover, the outperformance of short-term Treasury bonds underscores the shifting sentiment among traders, who now anticipate the possibility of the Fed’s initial rate adjustment occurring as early as June. This heightened expectation reflects a dynamic market response to evolving economic signals and central bank communications. Overall, the surge in the S&P 500 and the broader market rally signal investor confidence in the Federal Reserve’s commitment to navigating economic challenges and supporting continued growth through strategic monetary policy adjustments.

According to CNBC, the Bank of England is anticipated to maintain its interest rates at 5.25% amid recent economic data showing a decline in headline inflation to 3.4% in February, the lowest level since September 2021. This drop, along with weaker labor market indicators, has fueled speculation about potential rate cuts. With the UK economy slipping into a technical recession at the end of 2023 due to various factors including a gas supply shock following the Ukraine crisis, the Bank of England is under pressure to support economic recovery. Economists are divided on the timing of rate cuts, with some suggesting a possible reduction as early as June, aligning with market expectations. Despite the encouraging inflation figures, policymakers remain cautious, with uncertainties surrounding the extent and timing of rate adjustments. The Bank’s decision may hinge on further data, particularly on wage growth and services inflation, with some analysts suggesting a more prudent approach towards rate cuts, possibly in August. While the possibility of rate cuts signals a shift towards a less stringent monetary policy, uncertainties persist regarding the exact timing and extent of such measures. The Bank of England continues to monitor economic indicators closely as it navigates the path towards sustainable economic recovery.

On the stock market front, analysts are bearish on stocks such as U.S. Bancorp (NYSE:USB) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM) by lowering their price targets. For a comprehensive overview of these and other stocks affected by such adjustments, delve into the full article to explore the intricacies of the changes made to their price targets.

Photo by Adam Nowakowski on Unsplash

10. United States Steel Corporation (NYSE:X)

Price Reaction after the Price Target Cut: +0.88 (+2.26%)

On March 18, BMO Capital Markets reevaluated its perspective on United States Steel Corporation (NYSE:X), a key player in the steel manufacturing industry. Despite reducing the price target to $45 from the previous $55, the market responded positively, with the United States Steel Corporation stock price rising by 2.26% to $39.74 on the closing bell of March 19. BMO Capital Markets maintained a Market Perform rating on the stock amidst its revised outlook. The decision to lower the price target stemmed from a comprehensive analysis of United States Steel Corporation first-quarter performance, particularly focusing on earnings before interest, taxes, depreciation, and amortization (EBITDA). The steel manufacturer’s guidance for first-quarter EBITDA, approximately $425 million, fell within the initial forecast range of $400 to $450 million, indicating improvement from the fourth quarter of 2023, which stood at $330 million. The revised target reflects a cautious approach towards United States Steel Corporation ongoing strategic projects and potential risks associated with its transactions. While the company’s strategic initiatives are reportedly progressing as planned, the lack of recent updates on its future outlook, particularly regarding the transaction with Nippon, raised concerns. Additionally, heightened political pressure further contributed to the decision to lower the price target.

09. NIKE, Inc. (NYSE:NKE)

Price Reaction after the Price Target Cut: +1.22 (+1.24%)

On March 19, Wedbush, a prominent financial services firm, revised its outlook on NIKE, Inc. (NYSE:NKE), a major player in the athletic apparel and footwear industry. Despite reducing the price target from $131.00 to $115.00, the market reacted positively, with the stock price climbing by 1.24% to $99.96 on the closing bell of the same day. Wedbush maintained an “outperform” rating for the company in its research report. While the new target reflects a more conservative outlook, Wedbush remains optimistic about NIKE, Inc. prospects in the industry. NIKE, Inc. resilience and market position are key factors supporting Wedbush’s continued confidence in the company’s performance. Despite the adjustment in the price target, NIKE’s strong brand recognition, innovative product offerings, and global presence are expected to drive growth and maintain its competitive edge in the athletic apparel market. Wedbush’s “outperform” rating underscores its belief in NIKE, Inc. ability to outperform the broader market and deliver shareholder value over the long term. The rating reflects Wedbush’s confidence in NIKE, Inc. strategic initiatives, including its focus on digital transformation, sustainable practices, and expanding into new markets. Overall, while adjusting the price target downwards, Wedbush’s reaffirmation of an “outperform” rating reflects its continued bullish stance on NIKE, Inc. future prospects. The market’s positive reaction to the price target cut suggests investor confidence in NIKE’s resilience and growth potential despite the challenging market conditions.

Amalthea Fund stated the following regarding NIKE, Inc. in its fourth quarter 2023 investor letter:

“NIKE, Inc. (NYSE:NKE) of change of strategy: Fast forward a few years and Nike has had a change of strategy that was an Exocet to shoe industry retailers. Nike (who do not sell on Amazon) decided (accurately) that they had the hot product and wanted to drive sales through their own (mostly online) channels. They wanted to capture the retail margin.

Nike used to have 30,000 wholesale arrangements (retailers who sold their product). They cut this number sharply, down to 3000 and told people they were going to 1800. Small shoe retailers lost their core brand. Many failed…” (Click here to read the full text)

08. The Goldman Sachs Group, Inc. (NYSE:GS)

Price Reaction after the Price Target Cut: +4.29 (+1.12%)

On March 19, Oppenheimer adjusted its assessment of The Goldman Sachs Group, Inc. (NYSE:GS), a leading player in the global financial services industry. Despite lowering the price target from $506.00 to $446.00, the market responded positively, with the stock price increasing by 1.12% to $388.62 on the closing bell of the same day. Oppenheimer maintained an “outperform” rating for the company. The decision to reduce the price target was made following a comprehensive evaluation of The Goldman Sachs Group, Inc. performance and prevailing market conditions. Although the new target reflects a more conservative outlook, Oppenheimer remains optimistic about The Goldman Sachs Group, Inc. position in the industry. The Goldman Sachs Group, Inc. solid reputation, diversified business model, and strong financial performance are key factors supporting Oppenheimer’s continued confidence in the company’s prospects. Despite the adjustment in the price target, The Goldman Sachs Group, Inc. expertise in investment banking, wealth management, and trading operations are expected to drive growth and maintain its competitive edge in the financial services sector. Oppenheimer’s “outperform” rating underscores its belief in Goldman Sachs’ ability to outperform the broader market and deliver value to investors over the long term. The rating reflects Oppenheimer’s confidence in Goldman Sachs’ strategic initiatives, including its focus on technology-driven innovation, expanding client base, and adapting to regulatory changes.

Ariel Focus Fund stated the following regarding The Goldman Sachs Group, Inc. in its fourth quarter 2023 investor letter:

“Global investment bank, The Goldman Sachs Group, Inc. (NYSE:GS), also increased in the period on solid earnings results. The top-line came in strong led by elevated financing activity and an improvement in advisory revenues, despite weak transaction volumes within the investment banking segment. Should conditions remain conducive, management remains cautiously optimistic the business will experience continued recovery in both capital markets and strategy activity. Meanwhile, GS continues to successfully execute on its strategic initiatives to improve the overall return of the company. It is right sizing headcount and narrowing its ambitions in consumer strategy through divestitures and an enhanced focus on driving profitability in Platform Solutions by 2025. With potential regulatory capital constraints from B3E, GS noted it will reign in buybacks over the short-term but maintain its dividend. Looking ahead, we continue to view the near and long-term outlook for Goldman as attractive at current levels, given favorable business trends, continued positive momentum on strategic initiatives and active expense/capital management programs.”

07. Starbucks Corporation (NASDAQ:SBUX)

Price Reaction after the Price Target Cut: +0.58 (+0.64%)

On March 19, JPMorgan Chase & Co. made adjustments to its evaluation of Starbucks Corporation (NASDAQ:SBUX), a leading player in the coffeehouse industry. Despite reducing the price target from $107.00 to $100.00, the market responded modestly positively, with the stock price rising by 0.64% to $91.59 on the closing bell of the same day. JPMorgan Chase & Co. maintained an “overweight” rating for the stock. Starbucks Corporation strong brand presence, global footprint, and innovative strategies are key factors supporting JPMorgan Chase & Co.’s continued confidence in the company’s growth potential. Despite the adjustment in the price target, Starbucks Corporation resilience and ability to adapt to changing consumer preferences are expected to drive future success in the competitive coffee industry.

JPMorgan Chase & Co.’s “overweight” rating underscores its belief that Starbucks Corporation stock has the potential to outperform the broader market. The rating reflects JPMorgan Chase & Co.’s conviction in Starbucks’ ability to navigate challenges and capitalize on opportunities, such as expanding its digital offerings, enhancing customer experiences, and pursuing sustainable growth initiatives. Overall, while adjusting the price target downwards, JPMorgan Chase & Co.’s reaffirmation of an “overweight” rating reflects its continued bullish outlook on Starbucks Corporation future prospects. The market’s marginal positive response to the price target cut suggests investor confidence in Starbucks’ ability to maintain its market position and drive value creation over the long term.

06. JPMorgan Chase & Co. (NYSE:JPM)

Price Reaction after the Price Target Cut: +1.13 (+0.59%)

On March 19, Oppenheimer made adjustments to its evaluation of JPMorgan Chase & Co., a major player in the banking and financial services industry. Despite lowering the price target from $238.00 to $219.00, the market responded with a slight increase, with the stock price rising by 0.59% to $193.86 on the closing bell of the same day. Oppenheimer maintained an “Outperform” rating for the company. The decision to reduce the price target was based on a comprehensive assessment of JPMorgan Chase & Co. performance and the prevailing market conditions. While the revised target reflects a more cautious outlook, Oppenheimer remains bullish on JPMorgan Chase & Co. long-term prospects. Overall, while adjusting the price target downwards, Oppenheimer’s reaffirmation of an “Outperform” rating reflects its continued positive outlook on JPMorgan Chase & Co. future prospects. The market’s marginal positive response to the price target cut suggests investor confidence in JPMorgan Chase & Co. ability to sustain its leadership position and deliver value to shareholders over the long term.

Carillon Eagle Growth & Income Fund stated the following regarding JPMorgan Chase & Co. in its fourth quarter 2023 investor letter:

“PNC Financial and JPMorgan Chase & Co. (NYSE:JPM) performed well due to more benign inflation data, which the market likely interpreted as a sign that a recession is now less likely to occur. Recall that historically speaking, banks are hyper-cyclical stocks and typically will trade lower if investors foresee a recession, because recessions tend to trigger loan losses.”

05. Legacy Housing Corporation (NASDAQ:LEGH)

Price Reaction after the Price Target Cut: -0.03 (-0.14%)

04. U.S. Bancorp (NYSE:USB)

Price Reaction after the Price Target Cut: -0.25 (-0.59%)

On March 19, Oppenheimer analyst Chris Kotowski revised the price target for U.S. Bancorp, a significant player in the financial services industry. Despite maintaining an “Outperform” rating for the company, Kotowski adjusted the price target downwards from $61.00 to $55.00. Following this announcement, the market response showed a slight decrease of 0.59%, with the stock price settling at $42.22 on the closing bell of the same day. While the revised target reflects a more conservative outlook, Kotowski maintains confidence in U.S. Bancorp ability to deliver solid results and generate value for shareholders. U.S. Bancorp position within the financial services industry, coupled with its robust fundamentals and strategic initiatives, are key factors supporting Kotowski’s continued endorsement of the company. Despite the adjustment in the price target, Kotowski believes that U.S. Bancorp remains well-positioned to navigate challenges and capitalize on growth opportunities in the dynamic financial landscape. The “Outperform” rating reaffirms Kotowski’s belief that U.S. Bancorp stock has the potential to outperform its peers and the broader market. This rating underscores Kotowski’s conviction in U.S. Bancorp strong business model, prudent risk management practices, and commitment to delivering shareholder value over the long term.

Artisan Value Fund stated the following regarding U.S. Bancorp in its fourth quarter 2023 investor letter:

“Banks were well represented among our top Q4 performers as the Treasury market rally drove big gains in the bank stocks. U.S. Bancorp (NYSE:USB), PNC Financial Services (PNC) and Bank of America—the three banks we hold in the portfolio—were each among our top five contributors to return. When bank stocks sold off in Q1 due to fears of contagion following Silicon Valley Bank’s failure, we took advantage of the market dislocation by purchasing top-10 US banks USB and PNC at what were, in our view, cheap prices. USB and PNC are banks we have known for years. They are well managed and well capitalized. As large banks, they were less impacted by the turmoil that affected smaller institutions as depositors sought the safest places to store their money. The recent rebound is an example of how our approach of investing in out-of-favor businesses can lead to alpha. USB and PNC are not immune from industry-wide headwinds from higher deposit costs, pressured net interest margins and fleeing deposits. However, we did not see these banks having a similar level of risk, with respect to uninsured deposits and unrealized losses, which contributed in varying degrees to the collapses of other banks in March 2023. As investors, we cannot avoid risk. However, we are willing to take risk if we are being compensated appropriately.”

03. Bitcoin Depot Inc. (NASDAQ:BTM)

Price Reaction after the Price Target Cut: -0.0100 (-0.4149%)

On March 19, Wainwright analyst Mike Colonnese revised the price target for Bitcoin Depot Inc. (NASDAQ:BTM), a prominent player in the cryptocurrency industry. Despite maintaining a “Buy” rating for the company, Colonnese adjusted the price target downwards from $6.00 to $5.00. Following this announcement, the market response showed a slight decrease of 0.4149%, with the stock price settling at $2.40 on the closing bell of the same day. Colonnese’s decision to lower the price target was driven by a thorough assessment of Bitcoin Depot Inc. performance and the prevailing market dynamics. While the revised target reflects a more conservative outlook, Colonnese maintains confidence in Bitcoin Depot Inc. long-term growth prospects and its ability to capitalize on opportunities in the cryptocurrency space. Bitcoin Depot Inc. position within the cryptocurrency industry, coupled with its innovative solutions and strategic initiatives, are key factors supporting Colonnese’s continued endorsement of the company. Despite the adjustment in the price target, Colonnese believes that Bitcoin Depot Inc. remains well-positioned to benefit from the growing adoption of cryptocurrencies and the expanding digital asset ecosystem. The “Buy” rating reaffirms Colonnese’s belief that Bitcoin Depot Inc. stock presents an attractive investment opportunity for investors seeking exposure to the cryptocurrency market. This rating underscores Colonnese’s conviction in Bitcoin Depot’s business model, technological capabilities, and potential for sustained growth in the evolving digital currency landscape.

02. Adverum Biotechnologies, Inc. (NASDAQ:ADVM)

Price Reaction after the Price Target Cut: -0.1200 (-6.7797%)

01. Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP)

Price Reaction after the Price Target Cut: -0.4800 (-18.5328%)

On March 19, H.C. Wainwright analyst Ed Arce made revisions to the price target for Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), a prominent player in the pharmaceutical industry. Arce reduced the price target from $14.00 to $12.00. Following this announcement, there was a significant market response, with the stock price witnessing a substantial decline of 18.5328% to $2.11 on the closing bell of the same day. The revised target reflects a more conservative valuation, reflecting potential challenges and uncertainties facing the company. Acurx Pharmaceuticals, Inc. position within the pharmaceutical industry, along with its pipeline of innovative drug candidates and strategic initiatives, were key considerations in Arce’s assessment. Despite the downward revision in the price target, Arce remains cautious about the company’s near-term outlook and believes that Acurx Pharmaceuticals may encounter obstacles in achieving its growth objectives. The significant decrease in the stock price following the price target cut indicates a notable market reaction, underscoring investor concerns about Acurx Pharmaceuticals, Inc. future performance and prospects in the competitive pharmaceutical landscape. Overall, while revising the price target downwards, Arce’s decision to maintain coverage on Acurx Pharmaceuticals, Inc. reflects his cautious outlook on the company’s near-term prospects. The substantial market response highlights the significance of price target adjustments in influencing investor sentiment and market dynamics within the pharmaceutical industry.

You can also take a look at 10 Cheap Clean Energy Stocks To Buy According to Wall Street Analysts and 11 Most Undervalued Cybersecurity Stocks To Buy According To Analysts

Suggested articles:

• 12 Best Artificial Intelligence (AI) Stocks To Buy According to Financial Media
• 11 Oversold Energy Stocks You Can Buy Right Now
• Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks

This article is originally published at Insider Monkey.